Engel AG, Lambert EH, Howard FM: Immune complexes (IgG and C3) at motor end-plate in myasthenia gravis. Mayo Clin Proc 52:267, 1977.
Engel AG, Lambert EH, Santa T: Study of long-term anticholinesterase therapy. Neurology 23:1273, 1973.
Engel AG, Ohno K, Sine SM: Congenital myasthenic syndromes: Progress over the past decade. Muscle Nerve 27:4, 2003.
Engel AG, Tsujihata M, Lambert EH, et al: Experimental autoimmune myasthenia gravis: A sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations. J Neuropathol Exp Neurol 35:569, 1976.
Engel AG, Tsujihata M, Lindstrom JM, Lennon VA: The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. Ann N Y Acad Sci 274:60, 1976.
Engel AL, Arahata K: The membrane attack complex of complement at the endplate in myasthenia gravis. Ann N Y Acad Sci 505:326, 1987.
Evoli A, Tonali P, Padua L, et al: Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126:2304, 2003.
Fambrough DM, Drachman DB, Satyamurti S: Neuromuscular junction in myasthenia gravis: Decreased acetylcholine receptors. Science 182:293, 1973.
Fariello R, Meloff K, Murphy EG, et al: A case of Schwartz-Jampel syndrome with unusual muscle biopsy findings. Ann Neurol 3:93, 1978.
Fontaine B, Khurana TS, Hoffman EP, et al: Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene. Science 250:1000, 1990.
Fontaine B, Vale Santos JM, Jurkat-Rott JK, et al: Mapping of hypokalemic periodic paralysis (hypo PP) to chromosome 1q31-q32 by a genome-wide search in three European families. Nat Genet 6:267, 1994.
Fukunaga H, Engel AG, Osane M, et al: Paucity and disorganization of presynaptic membrane active zones in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 5:686, 1982.
Gajdos P, Chevret S, Clair B, et al: Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Ann Neurol 41:789, 1997.
Gajdos P, Tranchant C, Clair B, et al: Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: A randomized double-blind clinical trial. Arch Neurol 62:1689, 2005.
Gamstorp I: Adynamia episodica hereditaria. Acta Paediatr Scand 45(Suppl 108):1, 1956.
Greer M, Schotland M: Myasthenia gravis in the newborn. Pediatrics 26:101, 1960.
Grob D, Brunner NG, Namba T: The natural course of myasthenia gravis and effect of therapeutic measures. Ann N Y Acad Sci 377:652, 1981.